Mirage News·3 min read·medium
Oral Semaglutide Cuts Heavy Drinking, CU Trial Finds
✦AI Summary
A clinical trial at CU Anschutz indicates that oral semaglutide significantly reduces heavy drinking in adults with Alcohol Use Disorder. This finding offers a potential new treatment path for a condition that has seen no new FDA-approved medications in nearly two decades.
A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD).
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in